Encore Dermatology
Hospitals & Physicians Clinics · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4900 Gettysburg Rd, Columbus, Ohio, 4322...Phone Number
(844) 848-6543Website
www.encoredermatology.comRevenue
$11.9 MillionIndustry
About Encore Dermatology
Encore Dermatology Org Chart
Is Encore Dermatology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Encore Dermatology recently announced quarterly report
Encore Dermatology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Encore Dermatology
Product Launch: Get notified when Encore Dermatology launches new products
Click to see if Encore Dermatology had a recent Job posting/layoffs
Check out if Encore Dermatology is spiking on competitors!
Check if Encore Dermatology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Encore Dermatology has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Encore Dermatology
Compare insights from companies similar to Encore Dermatology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Encore Dermatology is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Encore Dermatology is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Encore Dermatology.
Encore Dermatology financials insights
Gather financial insights about Encore Dermatology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$12M
Unspecified
$20M
Debt
$350K
Encore Dermatology Tech Stack
A closer look at the technologies used by Encore Dermatology
Encore Dermatology News & Media
Encore Dermatology secures $20 mln from Horizon
Horizon has provided a $20 million venture loan facility to Encore Dermatology. Headquartered in Malvern, Pennsylvania, Encore Dermatology is a specialty dermatology company. Encore is backed by EW Healthcare Partners, 1315 Capital and Longitude Capital.Horizon Technology Finance Provides $20 Million Venture Loan Facility to Encore Dermatology
FARMINGTON, Conn. and MALVERN, Pa., April 8, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
MALVERN, Pa.--(BUSINESS WIRE)--Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius Pharma LLC. Bob Moccia, Encore Dermatology President and CEO, states: “We arePromius Pharma, LLC. (a Wholly Owned Subsidiary of Dr. Reddy’s Laboratories Ltd.) Announces the Sale and Assignment of the US Rights for Its Marketed Dermatology Brands to Encore Dermatology
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISEB® Topical Cream and TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) in the United States
Top Hospitals & Physicians Clinics Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Encore Dermatology
Encore Dermatology, located in Columbus, OH, specializes in general, surgical, and cosmetic dermatology, offering a range of services from routine examinations to advanced treatments for skin conditions. The practice combines medical and spa treatments to help clients achieve their skincare goals in a relaxed environment. Their offerings include va... Read More